文献速递多重用药老年慢病共病管理

养老院帕金森病药物给药时间偏差与禁忌用药回顾性队列研究

Parkinson's Disease Medication Administration Timing Deviations and Contraindicated Medicine Use in Residential Aged Care: A Retrospective Cohort Study.
PubMed 文献 · J Am Med Dir Assoc · 2025-10-09

结果显示所有居民均出现超过30分钟的给药时间偏差,25.6%的已给药剂量时间偏差超过30分钟,12.4%的居民使用了禁忌药物。

要点

  • 所有接受帕金森病药物的养老院居民均出现超过30分钟的给药时间偏差。
  • 25.6%的已给药剂量在计划时间前后超过30分钟给予。
  • 12.4%的居民使用了帕金森病禁忌药物,最常见为甲氧氯普胺和利培酮。

核心结论

  • 养老院中帕金森病药物给药时间偏差广泛存在,需实施策略提高时间关键性治疗的依从性以改善症状管理。

主要发现

  • 共202名永久居民(占所有居民的7.9%)接受帕金森病药物。
  • 全部202名居民至少经历1次超过30分钟的给药时间偏差,98%的居民经历超过60分钟的偏差。
  • 166028剂计划剂量中1.1%(1776剂)未给予,72.8%的居民(147名)至少漏服1剂。
  • 164252剂已给药物中25.6%(42069剂)在计划时间前后超过30分钟给予,相当于每1000居民日605.8次错误时间事件(95%CI,572.0-641.6)。
  • 12.4%的居民(25名)使用了帕金森病禁忌药物,最常见为甲氧氯普胺(9/25,36%)、利培酮(8/25,32%)和阿立哌唑(5/25,20%)。

关键数值与推荐

  • 给药时间偏差定义为计划给药时间与实际给药时间的差异,采用30分钟和60分钟阈值量化。
  • 禁忌药物基于Beers标准判定。

临床怎么用

  • 养老院应关注帕金森病药物给药时间准确性,减少延迟或漏服。
  • 处方时应避免使用Beers标准中帕金森病禁忌药物如甲氧氯普胺、利培酮和阿立哌唑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Parkinson's disease (PD) is a common condition among older people and requires tailored, time-sensitive pharmacologic therapy for optimal symptom management. No prior studies have examined the extent to which doses of time-critical PD medicines are delayed or missed in residential aged care (RAC) settings. We aimed to identify deviations in PD medication administration timing and the use of medicines that are contraindicated in PD. DESIGN: A retrospective longitudinal cohort study. SETTING AND PARTICIPANTS: Twenty-three RAC facilities in New South Wales, Australia. Permanent residents aged ≥65 years who received PD medicines. METHODS: Routinely collected electronic data from January 1 to September 30, 2024, was used to investigate deviations in PD medication administration timing, defined as the difference between scheduled and actual administration times. We quantified the extent of dose administration timing deviation using 30-minute and 60-minute thresholds. The proportion of residents prescribed medicines contraindicated in PD, based on the Beers Criteria, was determined. RESULTS: A total of 202 permanent residents (7.9% of all residents) received PD medicines. All 202 residents experienced at least 1 instance of dose timing deviations of >30 minutes, and almost all (98%) experienced a deviation of >60 minutes during the 9-month study. Of 166,028 scheduled doses, 1.1% (n = 1776) were not administered and 72.8% of residents (n = 147) missed at least 1 dose. Of 164,252 total administered doses of PD medicines, 25.6% (n = 42,069) were given >30 minutes before or after the scheduled time, equivalent to 605.8 incidents of wrong timing per 1000 resident days (95% CI, 572.0-641.6). Contraindicated medicines were given to 12.4% of residents (n = 25) who received PD medicines. The most commonly administered contraindicated medicines were metoclopramide (9 of 25, 36%), risperidone (8 of 25, 32%) and aripiprazole (5 of 25, 20%). CONCLUSIONS AND IMPLICATIONS: Our study identified extensive deviations in dose timing of PD medicines in RAC. Implementing strategies to enhance adherence to prescribed schedules for time-critical treatments may improve symptom management for residents with PD and reduce additional negative health outcomes and associated health care costs.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Urwin R, Wabe N, Neupane S, et al. Parkinson's Disease Medication Administration Timing Deviations and Contraindicated Medicine Use in Residential Aged Care: A Retrospective Cohort Study. J Am Med Dir Assoc. 2025. PMID: 41022137. doi:10.1016/j.jamda.2025.105889

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。